Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Urology|January 1, 1990
Infrequent ras oncogene point mutations in renal cell carcinomaD M Nanus, I R Mentle, R J Motzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicityR J Motzer, M Mazumdar, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Effect of cytokine therapy on survival for patients with advanced renal cell carcinomaR J Motzer, M Mazumdar, J Bacik, et al.
Investigational New Drugs|July 30, 1999
A phase II study of pyrazoloacridine in patients with advanced renal cell carcinomaW J Berg, J McCaffrey, L H Schwartz, et al.
Cancer Genetics and Cytogenetics|August 1, 1993
A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumorsE Rodriguez, C Sreekantaiah, W Gerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-upL M Minasian, R J Motzer, L Gluck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapyM Mazumdar, D F Bajorin, J Bacik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinomaL Albiges, F Chamming's, B Duclos, et al.
British Journal of Cancer|January 14, 2012
Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinomaD Cella, A G Bushmakin, J C Cappelleri, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel in germ cell cancerR J Motzer, T C Chou, L Schwartz, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Urology|January 1, 1990
Infrequent ras oncogene point mutations in renal cell carcinomaD M Nanus, I R Mentle, R J Motzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicityR J Motzer, M Mazumdar, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Effect of cytokine therapy on survival for patients with advanced renal cell carcinomaR J Motzer, M Mazumdar, J Bacik, et al.
Investigational New Drugs|July 30, 1999
A phase II study of pyrazoloacridine in patients with advanced renal cell carcinomaW J Berg, J McCaffrey, L H Schwartz, et al.
Cancer Genetics and Cytogenetics|August 1, 1993
A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumorsE Rodriguez, C Sreekantaiah, W Gerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-upL M Minasian, R J Motzer, L Gluck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapyM Mazumdar, D F Bajorin, J Bacik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinomaL Albiges, F Chamming's, B Duclos, et al.
British Journal of Cancer|January 14, 2012
Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinomaD Cella, A G Bushmakin, J C Cappelleri, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel in germ cell cancerR J Motzer, T C Chou, L Schwartz, et al.
Pageof 16